Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PHIBRO ANIMAL HEALTH CORPPAHC · Entity 4671 | Chief Operating Officer | August 06, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PHIBRO ANIMAL HEALTH CORP
Report date August 06, 2026 · Filed September 17, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 38,275 |
Reported balance
After 2026-08-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-08-06 · Grant · Acquired 3,726 · Balance 38,275 F1: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock. F2: The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date. F3: This amendment to the Form 4 filed on August 10, 2026 (the "Original Form 4") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects the number of RSUs granted on August 6, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
F2: The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
F3: This amendment to the Form 4 filed on August 10, 2026 (the "Original Form 4") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects the number of RSUs granted on August 6, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2017 Filed Sep 8, 2017 01:13 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 810 | $11.83 | $9,582.30 |
DisclosureSEC source: 0001144204-17-047126 · v474773_4.xml · nonDerivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 01:13 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 4,237 | $35.55 | $150,625.35 |
DisclosureSEC source: 0001144204-17-047126 · v474773_4.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.10, inclusive. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 01:13 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 4,237 | $11.83 | $50,123.71 |
DisclosureSEC source: 0001144204-17-047126 · v474773_4.xml · nonDerivative · entry 1 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 09, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 32,771 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · derivative · entry 9 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,500 Underlying: Class A Common Stock · 32,771 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 09, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 32,771 | $31.55 | $1,033,925.05 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · nonDerivative · entry 6 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $32.70, inclusive. Read SEC document |
| May 09, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 32,771 | $11.83 | $387,680.93 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · nonDerivative · entry 5 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 08, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 3,218 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · derivative · entry 8 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,271 Underlying: Class A Common Stock · 3,218 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 08, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 3,218 | $30.00 | $96,540.00 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · nonDerivative · entry 4 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 08, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 3,218 | $11.83 | $38,068.94 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · nonDerivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 05, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 20,836 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · derivative · entry 7 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,489 Underlying: Class A Common Stock · 20,836 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 05, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 20,836 | $30.15 | $628,205.40 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45, inclusive. Read SEC document |
| May 05, 2017 Filed May 10, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 20,836 | $11.83 | $246,489.88 |
DisclosureSEC source: 0001571049-17-004766 · t1701523-f4.xml · nonDerivative · entry 1 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 04, 2017 Filed May 5, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 6,984 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004478 · t1701456_f4.xml · derivative · entry 6 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,325 Underlying: Class A Common Stock · 6,984 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 04, 2017 Filed May 5, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 6,984 | $30.26 | $211,335.84 |
DisclosureSEC source: 0001571049-17-004478 · t1701456_f4.xml · nonDerivative · entry 4 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive Read SEC document |
| May 04, 2017 Filed May 5, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 6,984 | $11.83 | $82,620.72 |
DisclosureSEC source: 0001571049-17-004478 · t1701456_f4.xml · nonDerivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 02, 2017 Filed May 5, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 11,969 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004478 · t1701456_f4.xml · derivative · entry 5 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,309 Underlying: Class A Common Stock · 11,969 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 02, 2017 Filed May 5, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 11,969 | $30.06 | $359,788.14 |
DisclosureSEC source: 0001571049-17-004478 · t1701456_f4.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive. Read SEC document |
| May 02, 2017 Filed May 5, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 11,969 | $11.83 | $141,593.27 |
DisclosureSEC source: 0001571049-17-004478 · t1701456_f4.xml · nonDerivative · entry 1 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 01, 2017 Filed May 2, 2017 01:04 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 10,383 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004291 · t1701363_f4.xml · derivative · entry 6 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,278 Underlying: Class A Common Stock · 10,383 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| May 01, 2017 Filed May 2, 2017 01:04 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 10,383 | $30.17 | $313,255.11 |
DisclosureSEC source: 0001571049-17-004291 · t1701363_f4.xml · nonDerivative · entry 4 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45, inclusive Read SEC document |
| May 01, 2017 Filed May 2, 2017 01:04 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 10,383 | $11.83 | $122,830.89 |
DisclosureSEC source: 0001571049-17-004291 · t1701363_f4.xml · nonDerivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| April 27, 2017 Filed May 2, 2017 01:04 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 4,397 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004291 · t1701363_f4.xml · derivative · entry 5 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,661 Underlying: Class A Common Stock · 4,397 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| April 27, 2017 Filed May 2, 2017 01:04 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 4,397 | $30.02 | $131,997.94 |
DisclosureSEC source: 0001571049-17-004291 · t1701363_f4.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13, inclusive. Read SEC document |
| April 27, 2017 Filed May 2, 2017 01:04 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 4,397 | $11.83 | $52,016.51 |
DisclosureSEC source: 0001571049-17-004291 · t1701363_f4.xml · nonDerivative · entry 1 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 367 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · derivative · entry 9 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,058 Underlying: Class A Common Stock · 367 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 367 | $30.00 | $11,010.00 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · nonDerivative · entry 6 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 367 | $11.83 | $4,341.61 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · nonDerivative · entry 5 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 940 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · derivative · entry 8 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,425 Underlying: Class A Common Stock · 940 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 940 | $30.00 | $28,200.00 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · nonDerivative · entry 4 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 940 | $11.83 | $11,120.20 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · nonDerivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 3,281 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · derivative · entry 7 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,365 Underlying: Class A Common Stock · 3,281 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 3,281 | $30.00 | $98,430.00 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 3,281 | $11.83 | $38,814.23 |
DisclosureSEC source: 0001571049-17-001432 · t1700530_x1.xml · nonDerivative · entry 1 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 22,139 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · derivative · entry 9 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,646 Underlying: Class A Common Stock · 22,139 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 22,139 | $30.04 | $665,055.56 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · nonDerivative · entry 6 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55, inclusive. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 22,139 | $11.83 | $261,904.37 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · nonDerivative · entry 5 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 45,528 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · derivative · entry 8 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,785 Underlying: Class A Common Stock · 45,528 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 45,528 | $30.57 | $1,391,790.96 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · nonDerivative · entry 4 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.80, inclusive. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 45,528 | $11.83 | $538,596.24 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · nonDerivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 29,562 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · derivative · entry 7 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,313 Underlying: Class A Common Stock · 29,562 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 29,562 | $30.30 | $895,728.60 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.40, inclusive. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 29,562 | $11.83 | $349,718.46 |
DisclosureSEC source: 0001571049-17-001289 · t1700411_x1.xml · nonDerivative · entry 1 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 187 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-000213 · t1700038-x2.xml · derivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,875 Underlying: Class A Common Stock · 187 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 187 | $30.00 | $5,610.00 |
DisclosureSEC source: 0001571049-17-000213 · t1700038-x2.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 187 | $11.83 | $2,212.21 |
DisclosureSEC source: 0001571049-17-000213 · t1700038-x2.xml · nonDerivative · entry 1 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 02:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,540 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-16-020777 · t1603145_x2.xml · derivative · entry 6 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,062 Underlying: Class A Common Stock · 1,540 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 02:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 1,540 | $30.04 | $46,261.60 |
DisclosureSEC source: 0001571049-16-020777 · t1603145_x2.xml · nonDerivative · entry 4 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 02:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 1,540 | $11.83 | $18,218.20 |
DisclosureSEC source: 0001571049-16-020777 · t1603145_x2.xml · nonDerivative · entry 3 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| December 19, 2016 Filed Dec 22, 2016 02:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 252 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-16-020777 · t1603145_x2.xml · derivative · entry 5 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,602 Underlying: Class A Common Stock · 252 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
| December 19, 2016 Filed Dec 22, 2016 02:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 252 | $30.00 | $7,560.00 |
DisclosureSEC source: 0001571049-16-020777 · t1603145_x2.xml · nonDerivative · entry 2 Miller Larry Lee · CIK 0001603584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.